The Hospice Comfort Kit: Managing Terminal Dyspnea and the Death Rattle at Home

When the Living Room Is the Unit

In home hospice, the crisis does not arrive at a resuscitation bay. It arrives in a bedroom, at 0300, with a frightened family member and a small box of pre-placed medications: the comfort kit (sometimes an e-kit) the agency positioned in the home for exactly this moment. Knowing what is in that kit and why is part of supporting these patients and the nurses who manage them, and it matters when we get the 911 call from a hospice home.

Terminal Dyspnea: Fan, Then Opioid, Oxygen Only for Hypoxemia

Air hunger near the end of life is one of the most distressing symptoms a family will witness. The ASCO guideline on dyspnea in advanced cancer (2021) lays out a hierarchy that matches what good hospice nurses already do:

• Look for the reversible cause first, within the goals of care.
• Airflow: a fan directed at the cheek provides some relief and costs nothing.
• Oxygen for hypoxemia: the guideline supports standard supplemental oxygen for patients who are hypoxemic. Air hunger and low saturation are not the same problem, and a cannula on a patient with a normal SpO2 is not the first move.
• Systemic opioids when nonpharmacologic measures don't give enough relief. In the kit, that is usually low-dose morphine, titrated to the patient's comfort, not to a respiratory number.

The guideline is honest that support for pharmacologic interventions is limited. The opioid is still the drug with the most behind it, and in practice the dose that relieves air hunger at the end of life is small.

The Death Rattle: Reposition First, Then Manage Expectations

The "death rattle" is the noisy breathing caused by pooled oropharyngeal secretions in a patient who has lost the ability to swallow or cough. It occurs in up to half of dying patients, and it distresses the family far more reliably than anything we can measure in the usually unconscious patient.

• Reposition first. Lateral or semi-prone positioning lets secretions drain and is often enough.
• Antimuscarinics reduce new secretion production; they do not clear what has already pooled. The kit may hold glycopyrrolate, atropine 1% ophthalmic drops given sublingually, or scopolamine (hyoscine).
• The evidence is weaker than the habit. A randomized trial of 137 hospice inpatients found a single sublingual dose of atropine was no better than placebo at reducing the noise at two or four hours. The more encouraging data are for prevention: in the SILENCE trial (JAMA, 2021), prophylactic subcutaneous scopolamine butylbromide started when the dying phase was recognized cut the rate of death rattle from 27% to 13%.

That is why the most useful intervention is often the conversation: explaining to the family what the sound is, and that it does not mean their person is choking.

Terminal Agitation and Restlessness

Restlessness at the end of life can be delirium, pain, a full bladder, constipation, or fear. Assess before you sedate.

• Haloperidol is the backbone of the trial evidence for agitated delirium.
• Lorazepam for anxiety, and as an add-on for severe agitation. In a randomized trial of patients with advanced cancer and agitated delirium, adding lorazepam to haloperidol reduced agitation at 8 hours more than haloperidol alone, and blinded caregivers rated those patients as more comfortable (84% vs 37%).
• Distinguish agitation from uncontrolled pain; the answer is different for each.

The Compliance Layer Nobody Sees

Once dispensed, the controlled drugs in that kit belong to the patient. The obligations that follow them are specific, and worth getting right:

• Medicare hospice conditions of participation (42 CFR 418.106) require the hospice to have written policies for managing and disposing of controlled drugs in the home, to give the family a copy and walk them through it when controlled drugs are first ordered, and to document that conversation in the clinical record.
• The SUPPORT Act of 2018 amended the Controlled Substances Act (21 U.S.C. 822(g)) so that a trained employee of a qualified hospice can dispose of a patient's controlled substances on site after the patient dies, when the drugs expire, or, for the hospice physician, when the plan of care changes. Outside that provision, disposal falls to the patient or to whoever is lawfully entitled to dispose of the decedent's property.
• Witnessed waste and the count in the home are hospice policy and state law, not a DEA recordkeeping requirement on the household. That is where mobile drug-log tooling earns its place: a second signature and a timestamp at the bedside.

I covered the disposal side in more depth in Bedside Wasting & e-Prescribing. The clinical job is comfort; the regulatory job is proving, after the fact, that every milligram went where it was supposed to.

Sources

• Journal of Clinical Oncology (PubMed) — Management of Dyspnea in Advanced Cancer: ASCO Guideline
• JAMA (PMC) — SILENCE: prophylactic scopolamine butylbromide for death rattle
• J Pain Symptom Manage (PubMed) — Sublingual atropine vs placebo for death rattle
• JAMA (PMC) — Lorazepam with haloperidol vs haloperidol alone for agitated delirium
• eCFR — 42 CFR 418.106, hospice drugs and biologicals, including disposal in the home
• Cornell LII — 21 U.S.C. 822(g), disposal of controlled substances by hospice employees